|
The purpose of this study is to determine whether stereotactic radiation therapy will improve outcomes over the standard treatment of surgery, radiation and chemotherapy.
Stereotactic radiotherapy (SRT) is a non-invasive radiotherapy method which allows for the delivery of higher doses of radiation to the tumor in the brain while sparing most of the surrounding normal brain tissue. SRT does not require sedation or hospital admission.
This study is for patients with the Glioblastoma Multiforme type of brain cancer. This is a Phase III trial.
To learn about specific treatment guidelines, call Saint Raphael's at the Hospital of Saint Raphael (203) 789-3545 or e-mail Pat Garofolo, M.S., B.S.N. study coordinator. You may also want to contact your physician for more information.
This page was last updated on 07/25/2003
|
